Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! By
Metabolomics Signature of Cardiovascular Disease in Patients With Diabetes, a Narrative Review Publisher



Dodangeh S1 ; Taghizadeh H1 ; Hosseinkhani S2 ; Khashayar P3 ; Pasalar P4 ; Meybodi HRA5 ; Razi F2 ; Larijani B1
Authors

Source: Journal of Diabetes and Metabolic Disorders Published:2023


Abstract

Objectives: The exact underlying mechanism of developing diabetes-related cardiovascular disease (CVD) among patients with type 2 diabetes (T2D) is not clear. Metabolomics can provide a platform enabling the prediction, diagnosis, and understanding of the risk of CVD in patients with diabetes mellitus. The aim of this review is to summarize the available evidence on the relationship between metabolomics and cardiovascular diseases in patients with diabetes. Methods: The literature was searched to find out studies that have investigated the relationship between the alteration of specific metabolites and cardiovascular diseases in patients with diabetes. Results: Evidence proposed that changes in the metabolism of certain amino acids, lipids, and carbohydrates, independent of traditional CVD risk factors, are associated with increased CVD risk. Conclusions: Metabolomics can provide a platform to enable the prediction, diagnosis, and understanding of the risk of CVD in patients with diabetes mellitus. The association of the alteration in specific metabolites with CVD may be considered in the investigations for the development of new therapeutic targets for the prevention of CVD in patients with diabetes mellitus. © 2023, The Author(s), under exclusive licence to Tehran University of Medical Sciences.
Related Docs
View other Related Docs
1. Metabolomics Profile and 10-Year Atherosclerotic Cardiovascular Disease (Ascvd) Risk Score, Frontiers in Cardiovascular Medicine (2023)
2. Evaluating the Association Between Amino Acid and Acylcarnitine Profiles and Different Levels of Coronary Artery Disease Risk in Postmenopausal Women Using Targeted Metabolomics Technique, Menopause (2022)
3. Circulating Amino Acids and Acylcarnitines Correlated With Different Cac Score Ranges in Diabetic Postmenopausal Women Using Lc–Ms/Ms Based Metabolomics Approach, BMC Endocrine Disorders (2022)
Experts (# of related papers)
View all Related Experts
Bagher Larijani (6)
Farideh Razi (5)
Other Related Docs
4. Evaluation of Metabolic Profile of Plasma Amino Acids in Diabetic Patients With Cardiovascular Diseases, Iranian Journal of Diabetes and Metabolism (2020)
5. Cardiovascular Outcomes of Sglt-2 Inhibitors’ Subtypes in Type 2 Diabetes; an Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials, Journal of Diabetes and Metabolic Disorders (2025)
6. Obesity-Related Metabolomic Profiles and Discrimination of Metabolically Unhealthy Obesity, Journal of Proteome Research (2018)
7. Trimethylamine N-Oxide As a Potential Risk Factor for Non-Communicable Diseases: A Systematic Review, Endocrine# Metabolic and Immune Disorders - Drug Targets (2023)
8. Metabolomics and Cell Therapy in Diabetes Mellitus, International Journal of Molecular and Cellular Medicine (2019)
9. Can Hdl Cholesterol Be Replaced by Paraoxonase 1 Activity in the Prediction of Severe Coronary Artery Disease in Patients With Type 2 Diabetes?, Nutrition# Metabolism and Cardiovascular Diseases (2023)
10. Nutrient Sensing Pathway Genes Expression Dysregulated in Patients With T2dm and Coronary Artery Disease, Diabetes Research and Clinical Practice (2019)
11. The Association Between Acylcarnitine and Amino Acids Profile and Metabolic Syndrome and Its Components in Iranian Adults: Data From Steps 2016, Frontiers in Endocrinology (2023)
12. Comparison of Serum Lp-Pla2 Level and Some Nutritional Factors Between Well-Controlled and Poorly-Controlled Diabetic Patients, Acta Medica Iranica (2015)
13. Association Between Type 2 Diabetes and Branched Chain Amino Acids (Bcaa); a Case-Control Study, Journal of Diabetes and Metabolic Disorders (2023)
14. Prevalence of Metabolic Syndrome in Iran: A 2011 Update, Journal of Diabetes (2017)
15. Elevated Angiopoietin-Like Protein 3 Serum Levels in Diabetic Nephropathy Patients and Its Association With Renal Function and Lipid Profile, BMC Nephrology (2023)
16. Hyperhomocysteinemia and Increased Risk of Coronary Artery Disease in Iranian Patients With Diabetes Mellitus Type Ii: A Cross-Sectional Study, Comparative Clinical Pathology (2020)
17. Lecithin-Cholesterol Acyltransferase (Lcat) Activity Is Lower in Patients With Type 2 Diabetes in the Presence of Metabolic Syndrome, Bioactive Compounds in Health and Disease (2020)
18. The Comparison of Serum Vaspin and Visfatin Concentrations in Obese and Normal Weight Women, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2015)
19. Comparison of the Prevalence of Metabolic Syndrome in Military and Non-Military (Civilian) Personnel and Its Relationship With Lifestyle, Journal of Military Medicine (2021)
20. The Association Between Dietary Diabetic Risk Reduction Score With Anthropometric and Body Composition Variables in Overweight and Obese Women: A Cross-Sectional Study, Scientific Reports (2023)